| NCT ID | NCT07250997 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Szeged University |
| Condition | Vitiligo Vulgaris |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-12-10 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-12-10 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to get clinical experiences with the PALLAS laser in the treatment of skin conditions that respond well to UV light (vitiligo, psoriasis, alopecia areata, atopic dermatitis). The secondary objective is to assess how user-friendly is the Pallas laser in the treatment of skin diseases. The patient in the trial will receive UVB laser treatment (2 treatments per week for up to 3 months). The treatments will be carried out by the doctors participating in the trial. The treatment takes approximately 10 minutes per session, and can last up to 3 months per patient. Photographic documentation of the lesions to be treated and the lesions treated is taken at the start of the examination and then once a month. At the end of the study, the patient rates the treatment and improvement on a Patient Satisfaction Scale.
Eligibility Criteria
Inclusion Criteria: 1. The subject understands the information provided, gives informed consent to participate in the study and is deemed by the investigator to be able to participate, 2. a skin condition that is expected to respond well to targeted UVB treatment, 3. a signed consent form. Exclusion Criteria: 1. Patient under 18 years of age, 2. pregnancy 3. epilepsy, 4. fever, infectious diseases, 5. the patient is within one month or currently enrolled in another clinical trial.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07250997 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Vitiligo Vulgaris. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07250997 currently recruiting?
Yes, NCT07250997 is actively recruiting participants. Contact the research team at kemeny.lajos@med.u-szeged.hu for enrollment information.
Where is the NCT07250997 trial being conducted?
This trial is being conducted at Szeged, Hungary.
Who is sponsoring the NCT07250997 clinical trial?
NCT07250997 is sponsored by Szeged University. The trial plans to enroll 50 participants.